샘플 요청 목록

 카트 문의
시장보고서
상품코드
1779736

세계의 셀리악병 치료 시장

Celiac Disease Treatment
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 371 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 셀리악병 치료 시장은 2030년까지 11억 달러에 달할 전망

2024년에 5억 9,710만 달러로 추정되는 세계의 셀리악병 치료 시장은 분석 기간인 2024-2030년에 CAGR 11.2%로 성장하며, 2030년에는 11억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 비타민·미네랄 치료는 CAGR 12.9%를 기록하며, 분석 기간 종료시에는 5억 8,680만 달러에 달할 것으로 예측됩니다. 무글루텐 음식 치료 분야의 성장률은 분석 기간 중 CAGR 10.3%로 추정됩니다.

미국 시장은 1억 6,270만 달러로 추정, 중국은 CAGR 15.5%로 성장 예측

미국의 셀리악병 치료 시장은 2024년에 1억 6,270만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 분석 기간인 2024-2030년의 CAGR 15.5%로 추이하며, 2030년에는 2억 3,750만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 7.9%와 10.0%로 예측됩니다. 유럽에서는 독일이 CAGR 약 8.9%로 성장할 것으로 예측됩니다.

세계의 셀리악병 치료 시장 - 주요 동향과 촉진요인 정리

왜 셀리악병 치료에 대한 수요가 증가하는가?

글루텐 관련 질환에 대한 인식 증가, 진단 기술의 향상, 전 세계 셀리악병 유병률 증가로 인해 셀리악병 치료제에 대한 수요가 증가하고 있습니다. 셀리악병은 글루텐 섭취로 인해 발생하는 자가면역질환으로 장 장애, 흡수 장애, 다양한 건강 합병증을 유발하는 질환입니다. 셀리악병 진단을 받는 사람들이 늘어남에 따라 엄격한 글루텐 제거 식단 이외의 효과적인 치료법에 대한 수요가 증가하고 있습니다.

첨단 진단검사가 가능해짐에 따라 셀리악병을 더 빨리, 더 정확하게 파악할 수 있게 되었고, 치료를 필요로 하는 환자층이 확대되고 있습니다. 또한 글루텐 과민증과 진단되지 않은 셀리악병에 따른 장기적인 건강 위험에 대한 소비자의 인식이 높아지면서 의료적 개입에 대한 수요가 증가하고 있습니다. 효소를 이용한 치료, 면역치료, 장내세균총 조절 등 새로운 치료법 연구가 활발히 진행되면서 평생 식이제한에 대한 대안을 찾는 환자들에게 새로운 희망을 가져다주고 있습니다.

기술의 발전은 어떻게 셀리악병 치료를 개선하고 있는가?

생명공학, 정밀의료, 치료제 개발의 기술 혁신은 글루텐 회피에 그치지 않고 새로운 솔루션을 제공함으로써 셀리악병 치료에 변화를 가져오고 있습니다. 가장 중요한 발전 중 하나는 글루텐이 면역 반응을 일으키기 전에 소화관에서 글루텐을 분해하도록 설계된 경구용 효소 요법의 개발입니다. 이 효소를 이용한 치료는 환자가 실수로 글루텐에 노출되었을 때 증상과 장 장애를 완화할 수 있도록 고안된 치료법입니다.

또한 글루텐에 대한 신체의 반응을 변화시키는 면역조절제에 대한 연구도 진행되고 있습니다. 연구개발자들은 글루텐을 허용하도록 면역 체계를 재교육하거나 장질환을 유발하는 염증 반응을 차단하는 치료법을 개발하고 있습니다. 또한 장내세균총(마이크로바이옴) 연구의 발전으로 장내 환경을 건강하게 만들고, 장내 염증을 억제하는 프로바이오틱스를 이용한 치료의 새로운 가능성이 열리고 있습니다. 또한 유전자 스크리닝 툴의 통합으로 조기 진단 및 개인 맞춤형 치료 접근법을 개선하여 보다 효과적인 질병 관리가 가능해졌습니다.

셀리악병 치료 산업의 성장을 주도하는 시장 동향은?

무글루텐 의약품 및 건강 보조 식품에 대한 소비자 수요 증가는 셀리악병 치료 시장을 형성하는 가장 영향력 있는 동향 중 하나입니다. 식품과 의약품에 함유된 2차 오염과 숨겨진 글루텐의 영향에 대한 인식이 높아지면서 무글루텐 의료용 인증 제품 개발이 중요시되고 있습니다. 이러한 추세는 제약회사들이 의약품, 비타민제 및 기타 치료제가 셀리악병 환자에게 안전하다는 것을 보장하기 위해 노력하고 있습니다.

시장 성장에 영향을 미치는 또 다른 주요 동향은 질병 개량신약의 임상시험 확대입니다. 여러 제약회사들이 셀리악병 환자들에게 장기적인 치료법을 제공하기 위해 백신, 생물제제, 효소 기반 치료제의 임상시험을 활발히 진행하고 있습니다. 또한 식단 관리 및 증상 추적을 위한 디지털 건강 플랫폼과 모바일 앱의 통합은 환자가 병을 보다 효과적으로 관리할 수 있도록 돕고 있습니다. 규제 상황의 진전에 따라 새로운 셀리악병 치료제의 승인이 가속화되고, 식이요법에 국한되지 않는 보다 종합적인 치료 옵션이 제공될 것으로 기대됩니다.

셀리악병 치료 시장의 미래를 형성하는 주요 성장 촉진요인은 무엇인가?

셀리악병 치료 시장의 성장은 연구 자금 증가, 진단율 증가, 치료 혁신의 발전 등 여러 요인에 의해 이루어집니다. 주요 성장 요인 중 하나는 무글루텐 식단에 국한되지 않는 표적 치료제 개발에 있으며, 제약회사와 생명공학 기업의 역할이 확대되고 있다는 점입니다. 임상시험과 신약개발에 대한 적극적인 투자로 인해 셀리악병 치료제 파이프라인은 꾸준히 성장하고 있습니다.

시장을 형성하는 또 다른 중요한 촉진요인은 인지도 향상과 조기 발견을 위한 정부 및 의료기관의 노력의 활성화입니다. 많은 국가에서 미진단된 셀리악병에 대한 부담을 줄이기 위해 검진 프로그램 및 환자 교육 캠페인을 실시했습니다. 또한 식품기업과 제약기업의 협력으로 보다 효과적인 글루텐 검출 툴와 보다 안전한 식단 개발이 진행되고 있습니다. 과학이 새로운 치료 경로를 계속 발견함에 따라 셀리악병 관리의 미래는 맞춤형 의료, 식이요법, 의약품 개입의 조합을 포함하게 될 것이며, 전 세계 환자의 삶의 질을 향상시킬 수 있을 것으로 보입니다.

부문

치료(비타민·미네랄 치료, 무글루텐 음식 치료, 의료 요법 치료), 투여 경로(경구투여 경로, 비경구투여 경로), 유통 채널(병원 유통 채널, 연구 센터 유통 채널, 기타 유통 채널)

조사 대상 기업의 예

  • 9 Meters Biopharma, Inc.
  • Anokion SA
  • Barinthus Biotherapeutics
  • Chugai Pharmaceutical Co., Ltd.
  • Cour Pharmaceuticals
  • Equillium, Inc.
  • Falk Pharma GmbH
  • Immunic, Inc.
  • ImmunogenX
  • Mozart Therapeutics
  • Nemysis Ltd
  • Novartis AG
  • Pfizer Inc.
  • Precigen ActoBio
  • Protagonist Therapeutics, Inc.
  • Provention Bio, Inc.
  • Sanofi
  • Takeda Pharmaceutical Company Limited
  • Theriva Biologics
  • Zedira GmbH

AI 통합

당사는 검증된 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.08.06

Global Celiac Disease Treatment Market to Reach US$1.1 Billion by 2030

The global market for Celiac Disease Treatment estimated at US$597.1 Million in the year 2024, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 11.2% over the analysis period 2024-2030. Vitamins & Minerals Treatment, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach US$586.8 Million by the end of the analysis period. Growth in the Gluten-Free Diet Treatment segment is estimated at 10.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$162.7 Million While China is Forecast to Grow at 15.5% CAGR

The Celiac Disease Treatment market in the U.S. is estimated at US$162.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$237.5 Million by the year 2030 trailing a CAGR of 15.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.9% and 10.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.9% CAGR.

Global Celiac Disease Treatment Market - Key Trends & Drivers Summarized

Why Is the Demand for Celiac Disease Treatment Increasing?

The demand for celiac disease treatment is increasing due to rising awareness of gluten-related disorders, improved diagnostic techniques, and a growing prevalence of celiac disease worldwide. Celiac disease is an autoimmune condition triggered by gluten consumption, leading to intestinal damage, malabsorption, and a range of health complications. As more individuals are diagnosed with the condition, there is an increasing demand for effective treatment options beyond a strict gluten-free diet.

The availability of advanced diagnostic tests has led to earlier and more accurate identification of celiac disease, expanding the patient pool requiring treatment. Additionally, growing consumer awareness about gluten sensitivity and the long-term health risks associated with undiagnosed celiac disease has increased the demand for medical intervention. Research into novel therapies, including enzyme-based treatments, immunotherapies, and gut microbiome modulation, is gaining momentum, providing new hope for patients seeking alternatives to lifelong dietary restrictions.

How Are Technological Advancements Improving Celiac Disease Treatment?

Innovations in biotechnology, precision medicine, and therapeutic drug development are transforming celiac disease treatment by offering new solutions beyond gluten avoidance. One of the most significant advancements is the development of oral enzyme therapies designed to break down gluten in the digestive tract before it triggers an immune response. These enzyme-based treatments are being designed to help patients manage accidental gluten exposure, reducing symptoms and intestinal damage.

Another breakthrough is the exploration of immune-modulating drugs that can alter the body’s reaction to gluten. Researchers are developing therapies that aim to retrain the immune system to tolerate gluten or block the inflammatory response that causes intestinal damage. Additionally, advancements in gut microbiome research have opened new possibilities for probiotic-based treatments that promote a healthier intestinal environment and reduce celiac-related inflammation. The integration of genetic screening tools is also improving early diagnosis and personalized treatment approaches, ensuring more effective management of the disease.

Which Market Trends Are Driving Growth in the Celiac Disease Treatment Industry?

The increasing consumer demand for gluten-free pharmaceuticals and dietary supplements is one of the most influential trends shaping the celiac disease treatment market. As awareness grows about the impact of cross-contamination and hidden gluten in food and medications, there is a greater emphasis on developing certified gluten-free medical products. This trend is driving pharmaceutical companies to ensure that medications, vitamins, and other treatments are safe for individuals with celiac disease.

Another key trend influencing market growth is the expansion of clinical trials for disease-modifying drugs. Several pharmaceutical companies are actively conducting trials for vaccines, biologics, and enzyme-based therapies that aim to provide long-term relief for celiac disease patients. Additionally, the integration of digital health platforms and mobile apps for diet management and symptom tracking is helping patients manage their condition more effectively. As the regulatory landscape evolves, the approval of novel celiac disease treatments is expected to accelerate, providing more comprehensive care options beyond dietary modifications.

What Are the Key Growth Drivers Shaping the Future of the Celiac Disease Treatment Market?

The growth in the celiac disease treatment market is driven by several factors, including increased research funding, rising diagnosis rates, and advancements in therapeutic innovation. One of the primary growth drivers is the expanding role of pharmaceutical and biotech companies in developing targeted therapies that go beyond gluten-free diets. With strong investments in clinical trials and drug discovery, the pipeline for celiac disease treatments is steadily growing.

Another crucial driver shaping the market is the increasing government and healthcare initiatives to improve awareness and early detection. Many countries are implementing screening programs and patient education campaigns to reduce the burden of undiagnosed celiac disease. Additionally, collaborations between food companies and pharmaceutical firms are leading to the development of more effective gluten detection tools and safer dietary solutions. As science continues to uncover new treatment pathways, the future of celiac disease management will likely include a combination of personalized medicine, dietary support, and pharmaceutical intervention, ensuring better quality of life for patients worldwide.

SCOPE OF STUDY:

The report analyzes the Celiac Disease Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment (Vitamins and Minerals Treatment, Gluten-Free Diet Treatment, Medical Therapies Treatment); Route of Administration (Oral Route of Administration, Parenteral Route of Administration); Distribution Channel (Hospitals Distribution Channels, Research Centers Distribution Channels, Other Distribution Channels)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • 9 Meters Biopharma, Inc.
  • Anokion SA
  • Barinthus Biotherapeutics
  • Chugai Pharmaceutical Co., Ltd.
  • Cour Pharmaceuticals
  • Equillium, Inc.
  • Falk Pharma GmbH
  • Immunic, Inc.
  • ImmunogenX
  • Mozart Therapeutics
  • Nemysis Ltd
  • Novartis AG
  • Pfizer Inc.
  • Precigen ActoBio
  • Protagonist Therapeutics, Inc.
  • Provention Bio, Inc.
  • Sanofi
  • Takeda Pharmaceutical Company Limited
  • Theriva Biologics
  • Zedira GmbH

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Celiac Disease Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Prevalence of Celiac Disease Throws the Spotlight on Therapeutic and Dietary Management Solutions
    • Growing Awareness and Early Diagnosis Rates Propel Demand for Celiac Disease Treatment and Intervention Options
    • Unmet Need Beyond Gluten-Free Diets Expands the Addressable Market for Pharmacological Therapies
    • Innovation in Enzyme Therapy and Immune Modulation Strengthens the Business Case for Drug Development Pipelines
    • Increased Focus on Gut Barrier Protection Drives Interest in Novel Celiac Disease Therapeutic Mechanisms
    • Pipeline Advancements in Peptide-Based and Biologic Therapies Accelerate Industry Investment in Targeted Treatments
    • Rising Incidence of Non-Responsive Celiac Disease Spurs Clinical Demand for Advanced Treatment Alternatives
    • Growing Consumer Adoption of Gluten-Free Diets Drives Demand for Nutraceuticals and Functional Support Products
    • Regulatory Fast-Track Designations and Orphan Drug Incentives Support Accelerated Approval Pathways
    • Digital Tools and Symptom-Tracking Apps Enhance Patient Engagement and Treatment Adherence
    • Healthcare Provider Education and Specialist Referral Programs Improve Access to Celiac Disease Management
    • Expansion of Diagnostic Testing Infrastructure Fuels Earlier Intervention and Therapeutic Need
    • Global Gluten-Free Food Market Growth Supports Adjunctive Dietary Management Approaches
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Celiac Disease Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Celiac Disease Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Celiac Disease Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Celiac Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Vitamins & Minerals Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Vitamins & Minerals Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Vitamins & Minerals Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Gluten-Free Diet Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Gluten-Free Diet Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Gluten-Free Diet Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Medical Therapies Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Medical Therapies Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Medical Therapies Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Oral Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Oral Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Oral Route of Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Parenteral Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Parenteral Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Parenteral Route of Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Research Centers Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Research Centers Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Research Centers Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • JAPAN
    • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • CHINA
    • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • EUROPE
    • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Celiac Disease Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Celiac Disease Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Celiac Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • FRANCE
    • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • GERMANY
    • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Spain 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Russia 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Celiac Disease Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Celiac Disease Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Celiac Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Australia 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • INDIA
    • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: India 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: South Korea 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Celiac Disease Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Celiac Disease Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Celiac Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Argentina 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Brazil 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Mexico 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Celiac Disease Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Celiac Disease Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Middle East 15-Year Perspective for Celiac Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Iran 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Israel 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: UAE 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
  • AFRICA
    • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Africa 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제